ARA-290, also known as cibinetide, is a peptide developed from a tissue-protective region of erythropoietin. It is studied for its interaction with the innate repair receptor, a signalling complex involved in responses to inflammation and tissue injury used primarily to treat neuropathic pain, reduce chronic inflammation, and protect damaged nerve tissues
In simple terms: researchers study ARA-290 to understand how cells and nerves respond to injury and inflammatory stress.
This product is supplied for controlled laboratory research. Refer to the individual listing and batch documentation for the vial strength and product specifications.
Product Details
| Component | Details |
|---|---|
| Compound | ARA-290 |
| Also known as | Cibinetide |
| Research category | Innate repair receptor and tissue response research |
| Vial strength | As stated on the selected product listing |
Preclinical and laboratory research only
Innate repair signalling: Researchers examine how ARA-290 interacts with receptor pathways associated with cellular responses to injury.
Inflammatory responses: Preclinical studies investigate changes in inflammatory signalling following exposure to ARA-290 in models of tissue injury.
Nerve fibre research: Small clinical studies have examined ARA-290 in people with small nerve fibre loss, using measures such as symptoms and corneal nerve fibre density. Those studies do not establish the effects of this research-use product.
Research Use Notice
FOR RESEARCH PURPOSES ONLY. This Riptide product is intended for laboratory research and is not offered for human or veterinary use. It is not intended for therapeutic or diagnostic purposes. Handle and store according to applicable laboratory procedures and the product’s batch documentation.
